Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
about
Concepts of immunotherapy for gliomaChemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in miceClinical needs for hematopoietic growth factors: old and new.Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.All in the head: obstacles for immune rejection of brain tumours.The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.Vaccines in cancer: GVAX, a GM-CSF gene vaccine.Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gammaIL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells.The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumorsImmunocytokines: a review of molecules in clinical development for cancer therapy.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment.The potential applications of gene transfer in the treatment of patients with cancer: a concise review.Tumor immunotherapy by vaccination with cytokine gene transfected cells.A human recombinant IL-7/HGFβ hybrid cytokine enhances antitumor immunity in mice.Immunobiology of gliomas: new perspectives for therapy.Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.Cytokine gene modification of bladder cancer cells for the establishment of bladder cancer vaccine.Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system.Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.Expression of the tumor-rejection antigen SART1 in brain tumors.Immunocytokines
P2860
Q28083888-E7AA25C6-85C9-481E-BA0D-2499987D28D3Q28538913-8AA45965-A813-4C15-B284-321563E0CD77Q33497903-05EA8F8A-D38D-4A66-8772-E8ECE9FE0FEFQ34334817-50DC66BC-FDD8-40F7-8885-679FB5AF92E0Q34842204-E6122760-7B84-402E-9BC0-064E62113243Q36135662-DF35DA62-A002-465F-9A74-8459B5132F0CQ36198632-45B171C8-B13E-4A6A-A4C7-577ADC15230BQ36199032-4B18D7C0-2689-4A29-88C7-9D50FE1DD5E9Q37078985-8CC0734A-3F4E-430C-BCE0-90F0BA15047AQ37247954-4755D12D-32E5-46CF-A986-0016F10C0E4EQ38132742-DD3411B7-42C7-4FCC-AB29-C1E7702ED060Q38255481-3A578ADA-45CF-4FA0-9E61-8CAB0B462B17Q39543940-C08058B4-47DD-47D3-9B64-922D5D690DB4Q40603524-FACBF68C-0561-4303-BF9E-AC2491F94A0FQ41020855-6291496C-2197-410D-977A-13AE3E2E2092Q41455939-8003A7D4-8FF7-46D1-B0B2-54291B153270Q41547622-D9473A2C-066B-4110-8247-B52EA8F4D9D0Q41650683-6F169138-C0DE-4F45-AFFD-BFE4A13382E3Q41894129-AFD1C858-B114-4512-96B0-AA5968C788D0Q41993291-99A4EBCD-9E3A-4782-A581-8603C48525F2Q44059979-3879549A-55D1-4863-80E0-0BDAF176C496Q45858694-836DC2C6-FC32-47FD-A5A0-84C322B7AD8DQ48289670-9B505808-89FF-40CC-993A-8512A44A99C2Q51031723-BCF27D38-BFE0-4361-ABD9-AA99C2AAB4B9Q55476322-788F01BF-16FC-4F9A-9552-F751D26E89ECQ57911975-8844B0F8-F2F0-4F37-A195-7DBBBA2D9FF3
P2860
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of murine interleuk ...... educed tumorigenicity in vivo.
@en
Expression of murine interleuk ...... educed tumorigenicity in vivo.
@nl
type
label
Expression of murine interleuk ...... educed tumorigenicity in vivo.
@en
Expression of murine interleuk ...... educed tumorigenicity in vivo.
@nl
prefLabel
Expression of murine interleuk ...... educed tumorigenicity in vivo.
@en
Expression of murine interleuk ...... educed tumorigenicity in vivo.
@nl
P2093
P2860
P356
P1476
Expression of murine interleuk ...... educed tumorigenicity in vivo.
@en
P2093
Miyatake S
P2860
P304
P356
10.1073/PNAS.89.9.3850
P407
P577
1992-05-01T00:00:00Z